RetinalGenix Technologies (RTGN) Net Cash Flow Growth (3y) (2023 - 2026)
Powered by 
Analysis
RetinalGenix Technologies (RTGN) Net Cash Flow Growth (3y) (2023 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 29.78 Bn | 27.67 Bn | 2.18 Bn | 21.48% |
| 2 | Lantheus Holdings | 6.58 Bn | 5.99 Bn | 241.86 Mn | 54.12% |
| 3 | Heartflow | 4.12 Bn | 3.74 Bn | 53.19 Mn | - |
| 4 | Neogen | 2.60 Bn | 2.41 Bn | 107.80 Mn | -35.85% |
| 5 | Butterfly Network | 1.99 Bn | 1.86 Bn | 23.29 Mn | 21.26% |
| 6 | Ceribell | 922.09 Mn | 792.82 Mn | 25.94 Mn | - |
| 7 | QuidelOrtho | 883.12 Mn | 759.72 Mn | - | 53.55% |
| 8 | Varex Imaging | 779.06 Mn | 679.86 Mn | 76.70 Mn | -1.67% |
| 9 | Prenetics Global | 341.11 Mn | 282.06 Mn | 30.20 Mn | 31.01% |
| 10 | RetinalGenix Technologies | 75.37 Mn | 75.35 Mn | - | 90.08% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 90.08% |
| Mar 31, 2026 | -58.26% |
| Dec 31, 2025 | 82.80% |
| Sep 30, 2025 | -29.90% |
| Jun 30, 2025 | -4.34% |
| Mar 31, 2025 | 0.60% |
| Dec 31, 2024 | -32.17% |
| Sep 30, 2024 | -30.48% |
| Jun 30, 2024 | 495.46% |
| Mar 31, 2024 | 259.42% |
| Dec 31, 2023 | 88.36% |